≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Caries in Clefts patients

Endpoint Browser PheWeb

Q17_CLEFT_AND_CARIES

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • Q17_CLEFT_LIP_CLEFT_PALATE
625

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K02
  • Hospital discharge: ICD-10 — K02
  • Hospital discharge: ICD-9 — 5210A
  • Hospital discharge: ICD-8 — 52100
  • Cause of death: ICD-10 — K02
  • Cause of death: ICD-9 — 5210A
  • Cause of death: ICD-8 — 52100

3 out of 7 registries used, show all original rules.

374

4. Check minimum number of events

None

374

5. Include endpoints

None

374

6. Filter based on genotype QC (FinnGen only)

374

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4252 2191 2056
Only index persons 3920 2029 1891
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.06
Only index persons 0.07 0.07 0.07
Median age at first event (years)
Whole population 24.85 25.22 24.43
Only index persons 26.57 26.87 26.26

-FinnGen-

Key figures

All Female Male
Number of individuals 374 243 131
Unadjusted period prevalence (%) 0.07 0.08 0.06
Median age at first event (years) 36.37 37.58 34.14

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
327
Matched controls
3270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q35.1
ICD-10 Finland
Cleft hard palate
793.9
116.7
108
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
1232.0
97.2
90
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
415.4
68.2
66
*
K02.1
ICD-10 Finland
Caries of dentine
17.9
63.9
310
1650
4364
FHL
Pharyngeal tongue plastic
+∞
55.8
52
*
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
543.0
48.7
47
*
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
+∞
45.9
43
*
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
+∞
44.8
42
*
4362
FHL
Nozzle reconstruction
489.4
44.3
43
*
4122
FHL
Tympanostomy (tympanic tube)
18.1
41.0
65
44
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
+∞
37.2
35
*
4361
FHL
Lip plastic or reconstruction due to cleft lip
399.0
36.7
36
*
SBB10
NOMESCO Finland
Teeth copy
7.5
36.7
96
172
Q35.9
ICD-10 Finland
Cleft palate, unspecified
+∞
35.0
33
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
10.5
32.4
66
77
Q35.71
ICD-10 Finland
Submucous cleft palate
+∞
31.8
30
*
EAB30
NOMESCO Finland
Correction of cleft lip
318.7
29.3
29
*
4368
FHL
Closing the fistula of the mouth
+∞
28.6
27
*
7490C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS SUBMUCOSAE]
+∞
28.6
27
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.5
27.9
70
114
7490B
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]
+∞
26.4
25
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
8.7
26.2
59
81
74924
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis bilateralis
+∞
25.3
24
*
74929
ICD-8 Finland
Cleft palate and cleft lip, Unspecified
269.7
25.0
25
*
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
7.7
25.0
61
95
EB1MA
NOMESCO Finland
Cephalometry with X-ray
8.6
24.8
56
77
4365
FHL
Correction of nasal deformity
+∞
24.3
23
*
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
+∞
24.3
23
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
12.2
24.0
44
41
4367
FHL
Bone transfer to the upper jaw
+∞
23.2
22
*
EBB10
NOMESCO Finland
Insertion of dental implant
27.4
22.2
30
12
ZSZ10
NOMESCO Finland
Secondary repair operation
+∞
22.1
21
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.1
21.4
192
1021
WX110
NOMESCO Finland
Local anesthesy
3.9
21.0
278
1944
SFA10
NOMESCO Finland
Fillning on one surface of tooth
3.2
20.9
232
1418
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
3.2
20.0
242
1549
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
31.2
20.0
26
9
SAA03
NOMESCO Finland
Extended examination of mouth
3.0
19.6
192
1061
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.9
19.5
42
53
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
21.7
19.4
28
14
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
8.2
19.3
44
61
EHC40
NOMESCO Finland
Correction of submucous cleft palate
+∞
18.9
18
*
ECB17
NOMESCO Finland
Operation for cleft gingiva
106.2
18.8
20
*
EEC05
NOMESCO Finland
Le Fort I osteotomy
28.6
18.1
24
9
Q36.9
ICD-10 Finland
Cleft lip, unilateral
189.8
17.7
18
*
74910
ICD-8 Finland
Cleft palate and cleft lip, Cheiloschisis unilateralis
+∞
16.8
16
*
K00.00
ICD-10 Finland
Hypodontia
16.5
16.5
26
17
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
11.7
16.3
30
28
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
6.8
16.1
41
67
1450
FHL
Otomicroscopy
20.5
15.8
23
12
EHC10
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula of palate
+∞
15.7
15
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
40.2
15.6
19
5
SAA02
NOMESCO Finland
Basic examination of mouth
3.0
15.3
267
1952
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
8.5
14.7
32
41
9808
FHL
Bone graft
+∞
14.7
14
*
Q35.3
ICD-10 Finland
Cleft soft palate
156.7
14.6
15
*
4451
FHL
Guitar cutting
4.9
14.5
49
113
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
5.9
14.0
40
76
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
18.6
14.0
21
12
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
13.8
141
746
DLW00
NOMESCO Finland
Correction of cleft nose
+∞
13.6
13
*
EBA00
NOMESCO Finland
Extraction of tooth
2.5
13.6
147
802
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
13.0
136
723
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
13.0
12.8
22
18
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
6.3
12.8
34
59
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
6.7
12.6
32
52
EB1AA
NOMESCO Finland
Tooth X-ray examination
2.4
12.6
207
1375
EBB15
NOMESCO Finland
Insertion of dental implant abutment
21.1
12.6
18
9
4366
FHL
Upper jaw scar repair surgery
+∞
12.6
12
*
H66.9
ICD-10 Finland
Otitis media, unspecified
3.7
11.8
53
161
SAA01
NOMESCO Finland
Simple examination of mouth
2.7
11.7
269
2080
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
2.3
11.6
149
865
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.5
11.5
41
100
Q37.99
ICD-10 Finland
Cleft palate with cleft lip NOS
+∞
11.5
11
*
74912
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathoschisis unilateralis
+∞
11.5
11
*
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
7.3
11.4
27
40
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
36.4
11.4
14
*
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
26.1
11.2
15
6
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.0
122
655
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.2
10.8
220
1565
4347
FHL
Osteotomy of the upper jaw
+∞
10.5
10
*
4204
FHL
Molding of the cartilaginous part of the nose
+∞
10.5
10
*
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
4.9
10.4
34
76
Z2221
NOMESCO Finland
Medical doctor
2.4
10.4
115
612
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.0
9.7
58
216
DLD20
NOMESCO Finland
Rhinoplasty
56.7
9.7
11
*
UDC00
NOMESCO Finland
Ear microscopy
4.3
9.7
36
92
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
5.0
9.5
30
65
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
31.0
9.5
12
*
Q37.90
ICD-10 Finland
Unspecified cheft palate with cleft lip, unilateral
+∞
9.4
9
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.5
9.4
84
399
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.5
9.1
17
17
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
24.8
9.0
12
5
K07.14
ICD-10 Finland
Retrognaty, maxillary
13.0
9.0
15
12
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.9
8.9
17
18
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
51.4
8.7
10
*
WX290
NOMESCO Finland
Other blockade of nerve
2.0
8.6
190
1333
SJB60
NOMESCO Finland
External device grinding and adaptation
5.5
8.5
24
46
SXC05
NOMESCO Finland
Other oral or dental procedure
3.2
8.5
44
150
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
4.5
8.4
29
69
Z01.2
ICD-10 Finland
Dental examination
2.0
8.4
169
1143
4203
FHL
Mobilization and repositioning of the external pyramid
+∞
8.4
8
*
Q35.70
ICD-10 Finland
Cleft uvula
+∞
8.4
8
*
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
15.0
8.3
13
9
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
22.7
8.1
11
5
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
22.7
8.1
11
5
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.8
7.8
51
201
SPF20
NOMESCO Finland
Temporary soling for filling
25.7
7.6
10
*
R4130
NOMESCO Finland
Speech therapy
8.7
7.4
15
18
Q35
ICD-10 Finland
Cleft palate
+∞
7.3
7
*
7491A
ICD-9 Finland
Cleft palate and cleft lip, Cleft lip[CHEILOSCHISIS UNILATERALIS COMPLETA]
+∞
7.3
7
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
2.0
7.3
133
849
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
4.5
7.1
24
57
ZXA10
NOMESCO Finland
Bilateral
2.5
7.0
59
269
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
7.0
72
363
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
5.0
7.0
21
44
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
11.3
6.8
12
11
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
11.3
6.8
12
11
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
23.1
6.7
9
*
WZA90
NOMESCO Finland
Other doctors statement
2.0
6.7
92
526
DCD00
NOMESCO Finland
Myringoplasty
12.6
6.6
11
9
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
5.9
6.5
17
30
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
71.2
6.4
7
*
ZZG00
NOMESCO Finland
Graft of cartilage
71.2
6.4
7
*
SPB20
NOMESCO Finland
Temporary bridge between two or more teeth
14.7
6.4
10
7
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
18.4
6.3
9
5
SPF30
NOMESCO Finland
Soling for prothesis
18.4
6.3
9
5
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
18.4
6.3
9
5
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
18.4
6.3
9
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
6.2
87
500
K01.0
ICD-10 Finland
Embedded teeth
5.1
6.1
18
37
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
4.1
6.1
22
56
ZXE00
NOMESCO Finland
One hour or less
1.8
6.1
131
875
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.7
6.1
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
54
302
1.92
4.34
1.8
1.6
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
7
8.69
3.27
3.2
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
320
2911
1.69
3.18
12.9
9.9
mmol/l
139.7
139.6
0.16
314
2824
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
86
2.40
3.13
17.9
15.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
22
100
2.27
3.06
20.0
9.9
%
0.8
0.7
0.25
22
100
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
22
101
2.25
2.99
20.0
9.8
%
1.4
1.6
0.33
22
101
(3014007) Fractional oxyhemoglobin in Arterial blood
22
102
2.23
2.93
20.0
9.8
%
96.0
94.5
1.38
22
102
(3026389) Candida sp identified in Specimen by Organism specific culture
10
30
3.40
2.92
1.4
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
33
182
1.89
2.80
21.7
9.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
48
2.77
2.74
1.1
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
169
1.91
2.72
20.9
8.8
mmol/l
1.0
1.3
1.75
31
160
(3023103) Potassium [Moles/volume] in Serum or Plasma
318
2923
1.59
2.62
13.1
9.9
mmol/l
3.9
3.9
0.04
310
2827
(3052851) Hemolysis interference index of Serum or Plasma
16
68
2.41
2.59
1.6
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
94
699
1.46
2.49
2.8
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
67
2.29
2.20
1.1
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
82
611
1.44
2.13
3.6
3.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
37
2.75
2.12
18.1
12.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
75
2.18
2.11
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
108
847
1.39
2.10
2.4
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
10
5.05
2.07
1.0
1.2
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
5
10
5.05
2.07
3.4
4.5
mmol/l
1.2
3.3
—
5
10
(3024471) HLA-A [Type]
5
11
4.59
1.94
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
16
3.79
1.94
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
48
331
1.52
1.84
2.1
2.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
45
306
1.53
1.84
2.8
2.3
g/l
2.3
2.4
0.72
40
282
(3000494) Fungus identified in Specimen by Culture
44
299
1.53
1.80
1.3
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
523
0.64
1.80
1.3
1.3
u/ml
14.2
9.2
0.15
18
213
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
107
862
1.34
1.73
3.5
2.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
42
288
1.52
1.66
1.7
1.5
nmol/l
970.1
1218.5
1.11
32
235
(3013826) Glucose [Moles/volume] in Serum or Plasma
174
1510
1.28
1.61
6.7
4.7
mmol/l
6.5
6.4
0.45
156
1351
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
37
533
0.66
1.61
1.2
1.3
iu/ml
18.3
24.1
0.29
15
171
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
32
2.53
1.60
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
89
707
1.34
1.57
3.1
3.0
mmol/l
8.9
8.7
0.07
78
625
(3002582) Erythrocytes [#/volume] in Urine
94
757
1.32
1.51
3.1
2.7
e6/l
68.2
42.9
0.36
75
577
(3051611) Lipemic interference index of Serum or Plasma
6
21
2.89
1.51
2.2
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
163
1413
1.27
1.50
3.6
2.9
estimate
0.0
0.0
0.00
33
289
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
53
390
1.42
1.49
3.3
2.3
e6/l
1.4
0.8
0.79
30
208
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
52
2.15
1.46
6.5
5.6
—
5348.0
—
0
5
(3004119) Hemoglobin [Mass/volume] in Venous blood
18
103
1.79
1.43
13.1
7.5
g/l
122.6
131.5
0.70
18
103
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
54
402
1.40
1.43
3.5
3.1
ng/l
36.0
599.6
1.17
30
233
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
17
96
1.81
1.41
2.2
1.5
—
—
—
0
0
(4034850)
16
90
1.81
1.35
9.6
8.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
57
733
0.74
1.31
1.5
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
50
376
1.38
1.26
3.3
2.4
e6/l
3.7
2.7
0.36
28
193
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
17
101
1.72
1.22
2.8
2.7
ng/l
72.5
103.8
0.35
12
90
(3018095) Leukocytes [#/volume] in Urine
110
930
1.26
1.21
3.5
3.2
e6/l
96.2
91.7
0.02
79
615
(3026361) Erythrocytes [#/volume] in Blood
363
3542
1.84
1.19
17.3
14.6
e12/l
4.6
4.6
0.96
353
3455
(3030467) Casts [#/volume] in Urine by Automated count
84
688
1.28
1.19
3.2
2.6
e6/l
0.4
0.3
0.05
68
509
(3009261) Glucose [Presence] in Urine by Test strip
162
1434
1.23
1.17
3.7
3.0
estimate
0.0
0.0
0.50
31
286
(3021601) Nitrite [Presence] in Urine by Test strip
160
1415
1.23
1.16
5.2
4.1
estimate
0.0
0.0
0.50
31
300
(3012544) pH of Venous blood
29
200
1.49
1.16
13.1
7.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
5
20
2.52
1.15
1.4
1.3
u/l
64.6
92.1
—
5
14
(3044889) 12 lead EKG panel
191
1722
1.22
1.15
2.7
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
287
2702
1.27
1.14
10.0
8.2
ml/min/173m2
95.0
95.6
0.16
234
2162
(3010813) Leukocytes [#/volume] in Blood
363
3545
1.82
1.14
17.3
14.7
e9/l
6.7
6.6
0.34
353
3455
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
201
1.48
1.14
2.2
2.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
362
3536
1.74
1.08
17.4
14.7
e9/l
269.0
259.2
2.22
353
3453
(3020682) Albumin/Creatinine [Ratio] in Urine
66
531
1.29
1.08
3.8
3.9
mg/mmol
8.1
10.7
0.29
49
347
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
292
2762
1.26
1.07
4.6
4.5
mu/l
1.8
1.7
0.51
281
2614
(36304419) Bacteria [Presence] in Urine
84
699
1.26
1.05
2.9
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
63
506
1.29
1.04
3.0
3.2
mg/l
317.3
207.4
0.15
48
336
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
24
164
1.50
1.02
22.5
9.8
mmol/l
25.4
24.8
0.46
24
164
(4198724)
5
23
2.19
0.98
1.0
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
10
172
0.57
0.96
1.4
1.7
mg/l
2.8
2.5
—
5
113
(3000850) Epithelial cells [#/volume] in Urine
65
531
1.27
0.95
2.1
2.3
e6/l
11.0
6.9
0.97
57
459
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
982
1.22
0.95
10.7
6.9
mmol/l
1.2
1.2
1.03
105
912
(3048689) Calprotectin [Mass/mass] in Stool
38
492
0.75
0.93
3.2
2.9
ug/g
144.9
93.9
0.39
30
385
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
185
1.44
0.92
1.0
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
28
2.16
0.92
2.0
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
102
0.48
0.90
1.2
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
104
0.47
0.90
1.2
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
181
0.60
0.90
1.5
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
56
1.81
0.88
1.1
1.1
iu/ml
59.6
141.3
—
5
15
(3000492) Spirometry study
42
327
1.32
0.88
1.2
1.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
622
1.24
0.86
2.2
2.4
mg/l
3.0
2.7
0.37
64
537
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
31
408
0.74
0.85
1.8
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
294
0.70
0.84
1.5
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
249
2344
1.19
0.82
3.9
4.0
pmol/l
14.3
14.4
0.43
235
2190
(3017181) Myelocytes/100 leukocytes in Blood
28
207
1.38
0.82
4.0
4.5
%
1.1
1.0
—
6
57
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
292
0.70
0.81
1.1
1.3
iu/ml
204.2
176.7
—
9
116
(3020891) Body temperature
11
66
1.69
0.79
6.1
5.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
24
0.00
0.79
0.0
1.0
—
1.1
—
0
7
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
98
0.50
0.79
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
235
1.35
0.79
6.8
5.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
99
0.50
0.78
1.2
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
95
828
1.20
0.77
2.0
1.7
pmol/l
97.2
95.6
0.13
52
434
(3020779) Urea [Moles/volume] in Serum or Plasma
24
175
1.40
0.77
11.0
9.7
mmol/l
7.9
6.8
0.41
24
170
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
150
1.42
0.75
1.7
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
432
0.77
0.75
1.4
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
93
1058
0.84
0.75
1.9
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
54
1.68
0.75
2.3
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
24
2.10
0.75
1.0
2.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
38
1.86
0.74
2.3
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
274
1.31
0.73
1.5
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
289
2768
1.19
0.72
15.0
12.2
%
13.3
13.3
0.41
284
2725
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
109
1.49
0.72
1.6
1.4
u/ml
107.8
194.0
1.91
11
60
(3021440) Promyelocytes/100 leukocytes in Blood
26
195
1.36
0.71
4.0
4.6
%
0.2
0.2
—
6
51
(4010399)
21
152
1.40
0.71
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
18
127
1.44
0.69
1.1
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
27
1.86
0.68
1.2
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
109
1214
0.86
0.68
2.4
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
123
1111
1.16
0.65
3.7
2.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
155
1.38
0.64
3.2
5.5
mmol/l
1.0
0.9
0.06
13
110
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
5
29
1.73
0.64
1.2
2.4
%
11.6
9.3
—
5
23
(3018418) pH of Serum or Plasma
73
633
1.19
0.64
5.0
3.7
ph
7.4
7.4
0.49
11
107
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
390
1.23
0.63
1.7
1.5
pmol/l
466.1
38418510.0
0.80
40
354
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
101
0.59
0.63
1.3
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
113
1.43
0.62
1.6
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
125
1135
1.15
0.62
2.8
2.5
nmol/l
68.4
72.2
0.93
119
1054
(3032080) INR in Blood by Coagulation assay
87
769
1.17
0.61
7.6
4.9
inr
1.2
1.1
0.54
26
275
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
75
655
1.18
0.61
2.5
2.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
212
1998
1.14
0.60
4.1
3.7
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
3.3
—
24.3
—
0
20
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
20
0.00
0.60
0.0
1.0
—
94.3
—
0
12
(3050129) First trimester maternal screen panel - Serum or Plasma
22
287
0.75
0.60
1.4
1.4
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
21
0.00
0.60
0.0
5.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
204.1
—
0
21
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
21
0.00
0.60
0.0
2.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
111
0.62
0.59
1.6
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
161
0.67
0.58
1.4
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
54
1.49
0.57
2.9
5.0
umol/l
358.0
370.3
—
8
49
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
98
1.45
0.57
1.5
1.5
iu/ml
0.0
0.0
—
5
20
(3001122) Ferritin [Mass/volume] in Serum or Plasma
159
1476
1.13
0.56
3.2
2.9
ug/l
76.3
87.5
0.55
152
1394
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
79
698
1.17
0.56
1.5
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
177
1.32
0.56
3.6
3.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
38
1.59
0.54
1.5
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
278
2678
1.15
0.54
3.4
3.3
mmol/l
5.8
5.6
0.91
266
2493
(3023368) Bacteria identified in Blood by Culture
60
520
1.18
0.54
4.0
3.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
72
635
1.17
0.52
4.0
3.1
kg/l
1.0
1.0
0.64
11
88
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
197
1.29
0.52
1.4
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
83
1.46
0.52
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
83
1.46
0.52
1.0
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
120
1099
1.14
0.52
9.7
7.5
mmol/l
1.2
1.2
1.14
107
948
(3011288) Drugs identified in Urine by Screen method
15
202
0.73
0.52
1.5
2.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
266
0.78
0.48
1.5
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
46
1.53
0.48
1.6
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
254
0.78
0.47
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
109
999
1.13
0.47
1.7
1.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
94
1.40
0.46
2.2
4.1
g/l
0.1
0.2
—
5
55
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
49
1.44
0.46
1.0
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
436
0.83
0.46
1.3
1.4
titre
177.8
455.5
—
9
85
(21494755) Public health laboratory ask at order entry panel
44
510
0.84
0.45
1.3
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
37
312
1.21
0.45
1.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
229
1.24
0.45
2.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
72
802
0.87
0.45
1.3
1.4
g/l
2.1
2.1
0.02
46
509
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
10
69
1.46
0.44
8.7
1.8
nmol/l
0.5
0.8
—
10
59
(3023511) Choriogonadotropin [Units/volume] in Urine
21
166
1.28
0.44
1.2
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
102
935
1.13
0.44
7.1
6.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
252
2428
1.12
0.43
4.7
4.1
mmol/mol
38.6
37.7
0.56
243
2305
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
334
1.19
0.41
1.9
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
15
0.00
0.41
0.0
3.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
4.0
—
1.8
—
0
16
(3010503) CD19 cells [#/volume] in Blood
0
16
0.00
0.41
0.0
1.8
—
0.2
—
0
16
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
59
524
1.15
0.41
1.9
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
163
1540
1.10
0.40
7.1
6.2
e9/l
1.9
2.0
0.53
147
1386
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
3.7
—
0
18
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
18
0.00
0.40
0.0
1.8
—
16.1
—
0
6
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
23
187
1.25
0.40
1.3
1.3
miu/ml
265.4
260.9
0.02
13
96
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
19
0.00
0.39
0.0
1.0
—
134.0
—
0
19
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
19
0.00
0.39
0.0
1.0
—
103.7
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
12
89
1.36
0.38
1.8
2.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
82
749
1.12
0.38
3.6
3.1
estimate
0.0
0.0
0.80
32
295
(3025130) Human papilloma virus identified in Specimen
9
69
1.31
0.37
1.3
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
226
1.21
0.37
1.3
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
5
77
0.64
0.36
1.2
1.1
—
2.7
—
0
5
(3019060) Gas panel - Arterial blood
13
99
1.32
0.36
3.8
9.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
17
135
1.27
0.36
1.5
3.8
e9/l
61.8
72.5
—
10
101
(3006315) Basophils [#/volume] in Blood
157
1488
1.09
0.36
7.3
6.2
e9/l
0.0
0.0
0.02
138
1309
(3009542) Hematocrit [Volume Fraction] of Blood
314
3075
1.13
0.36
14.8
10.7
%
39.9
40.9
1.38
263
2609
(3003327) Ova and parasites identified in Stool by Light microscopy
16
126
1.28
0.36
1.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
27
227
1.20
0.35
2.0
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
17
211
0.80
0.35
3.6
3.7
pmol/l
4.4
4.8
1.29
17
189
(1616796) Gas panel - Central venous blood
6
43
1.40
0.35
1.8
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
179
1709
1.09
0.34
9.3
8.9
e9/l
4.2
3.9
0.90
154
1496
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
37
322
1.17
0.34
2.9
3.8
umol/l
5.0
8.3
1.32
31
273
(3001604) Monocytes [#/volume] in Blood
156
1482
1.09
0.33
7.3
6.2
e9/l
0.5
0.5
0.18
138
1307
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
77
707
1.11
0.33
1.5
1.6
mmol/l
1.3
1.4
0.07
69
620
(3001019) Free T4 and TSH panel - Serum or Plasma
21
251
0.83
0.32
1.5
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
84
777
1.10
0.31
2.8
2.6
ng/l
23.4
29.2
0.25
42
349
(3018010) Neutrophils/100 leukocytes in Blood
153
1456
1.09
0.31
6.9
6.0
%
57.3
55.5
1.12
142
1382
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
207
0.81
0.31
1.3
1.2
—
19.8
—
0
9
(3014051) Protein [Presence] in Urine by Test strip
7
54
1.30
0.30
2.0
1.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
75
1.34
0.30
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
111
1.27
0.30
1.9
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
30
260
1.17
0.30
2.7
2.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
19
227
0.83
0.29
2.4
2.2
—
22.9
—
0
16
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
295
2889
1.10
0.29
3.7
3.6
mmol/l
2.9
2.9
0.15
282
2724
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
12
94
1.29
0.28
2.4
1.5
—
—
—
0
0
(3013512) EKG study
50
551
0.89
0.28
3.4
2.7
—
—
—
0
0
(3026782) Osmolality of Urine
54
491
1.12
0.28
2.5
2.3
mosm/kgh2o
595.6
573.7
0.22
46
416
(3013115) Eosinophils [#/volume] in Blood
161
1542
1.08
0.27
7.5
6.7
e9/l
0.2
0.2
0.04
141
1384
(4035726)
22
188
1.18
0.26
1.7
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
37
413
0.88
0.26
2.2
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
126
0.79
0.24
1.9
2.1
u/l
32.5
39.7
—
10
116
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
10
78
1.29
0.24
7.2
4.1
%
63.9
52.6
—
10
78
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
35
313
1.13
0.24
3.4
2.9
%
18.5
23.5
1.03
12
95
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
327
3227
1.11
0.23
9.6
8.2
u/l
25.6
27.7
1.13
319
3138
(3022621) pH of Urine by Test strip
18
153
1.19
0.23
2.3
2.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
19
220
0.86
0.22
1.3
1.4
mu/l
265.9
313.4
0.62
19
195
(3009871) Measles virus Ab [Titer] in Serum
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
11
0.00
0.21
0.0
1.6
—
159.1
—
0
11
(3011436) Histone Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
2.8
—
108.9
—
0
12
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4146454)
0
12
0.00
0.21
0.0
3.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.6
—
49.3
—
0
12
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
199.1
—
0
12
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
25.8
—
0
12
(3008898) HLA-B27 [Presence]
17
198
0.85
0.21
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.5
—
16.2
—
0
13
(3027273) Bicarbonate [Moles/volume] in Venous blood
10
80
1.26
0.20
6.7
5.1
mmol/l
25.5
24.8
—
10
80
(21494890) Protein electrophoresis panel - 24 hour Urine
0
14
0.00
0.20
0.0
3.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
1.9
—
0
14
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
0.3
—
0
14
(40760892) CBC W Ordered Manual Differential panel - Blood
79
746
1.07
0.20
5.9
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
134
1289
1.06
0.20
5.8
5.8
umol/l
9.2
10.4
1.63
126
1226
(3028300) Cannabinoids [Presence] in Urine
26
291
0.89
0.20
1.4
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
50
1.20
0.20
12.5
3.6
e9/l
5.0
4.2
—
6
50
(3002030) Lymphocytes/100 leukocytes in Blood
152
1468
1.06
0.19
7.6
6.1
%
28.6
30.3
1.21
141
1394
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
51
1.18
0.19
13.0
4.1
%
59.2
57.9
—
6
51
(3006504) Eosinophils/100 leukocytes in Blood
145
1400
1.06
0.19
7.6
6.2
%
2.7
2.8
0.41
133
1315
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
209
2040
1.06
0.18
7.8
6.5
u/l
77.0
77.5
0.05
198
1923
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
779
1.07
0.18
2.5
2.9
mmol/l
2.4
2.4
0.53
69
710
(3000764) Benzodiazepines [Presence] in Urine
26
288
0.90
0.17
1.4
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
26
288
0.90
0.17
1.4
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
287
0.90
0.16
1.4
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
287
0.90
0.16
1.7
2.3
u/l
5723.8
4156.9
—
7
127
(3007566) Smooth muscle Ab [Titer] in Serum
11
92
1.20
0.16
1.3
1.4
—
62.0
—
0
10
(3028626) Oxygen [Partial pressure] in Capillary blood
11
92
1.20
0.16
4.6
5.7
kpa
9.4
9.3
0.13
11
85
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
42
390
1.09
0.16
6.3
2.9
ng/l
1424.6
582.5
0.50
33
305
(40761511) CBC panel - Blood by Automated count
331
3279
1.08
0.15
10.2
8.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
26
236
1.11
0.15
1.8
2.3
g/l
10.0
10.2
0.10
26
221
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
139
1349
1.05
0.15
4.2
3.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
145
1409
1.05
0.14
8.0
6.4
%
8.1
8.1
0.02
133
1335
(3041096) Erythrocytes [Presence] in Urine by Automated
90
864
1.05
0.14
2.9
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
139
0.86
0.14
1.4
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
139
1350
1.05
0.14
7.8
6.3
%
0.6
0.7
0.33
127
1267
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
232
0.90
0.13
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
232
0.90
0.13
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
14
159
0.88
0.13
2.9
4.5
ug/l
228.4
33.9
—
8
124
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
231
0.90
0.12
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
231
0.90
0.12
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
15
168
0.89
0.12
4.7
2.1
u/ml
52.5
46.2
0.07
15
160
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
290
2869
1.05
0.12
3.4
3.4
mmol/l
4.7
4.7
0.18
277
2724
(46235355) HIV 1 and 2 tests - Meaningful Use set
108
1112
0.96
0.11
1.7
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
789
0.95
0.11
1.9
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
115
0.87
0.11
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
11
96
1.15
0.10
1.2
1.5
—
266.7
—
0
6
(4268621)
5
46
1.09
0.09
1.8
2.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
87
1.15
0.09
1.2
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
116
1.13
0.09
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
48
502
0.95
0.09
2.2
1.8
%
1.5
1.4
0.29
42
466
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
84
865
0.96
0.09
2.1
2.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
103
1004
1.04
0.09
4.2
3.1
u/l
121.3
32.1
0.46
98
958
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
226
0.92
0.08
1.3
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
63
0.79
0.08
1.4
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.2
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
117
1.12
0.08
3.8
2.7
e6/l
0.3
0.1
0.60
13
112
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
65
0.77
0.08
1.4
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
210
2126
0.97
0.08
4.0
3.7
mm/h
9.7
8.4
0.79
203
1990
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
98
1.13
0.07
2.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
70
0.85
0.07
1.0
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
176
1.08
0.07
1.7
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
82
0.85
0.07
1.6
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
84
0.83
0.07
1.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
532
1.04
0.07
1.5
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
288
2860
1.03
0.06
3.3
3.4
mmol/l
1.4
1.5
0.57
276
2708
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
59
608
0.96
0.06
1.5
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
325
1.05
0.06
1.2
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
213
0.94
0.06
2.5
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
37
355
1.05
0.06
2.5
2.3
mmol/l
2.4
2.4
0.76
32
310
(3043238) Trisomy 21 risk [Likelihood] in Fetus
18
192
0.93
0.05
1.5
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
141
1392
1.02
0.05
9.2
8.0
e9/l
0.0
0.0
0.35
113
1136
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
91
1.10
0.04
1.8
1.3
pmol/l
63.9
52.6
—
10
86
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
307
3083
0.98
0.03
12.3
10.0
mg/l
19.4
20.2
0.17
228
2294
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
151
1.06
0.03
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
34
330
1.03
0.03
1.4
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
277
2758
1.02
0.03
4.0
3.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
64
651
0.98
0.03
2.7
2.1
u/l
219.7
279.3
0.19
58
628
(40758558) Short blood count panel - Blood
74
729
1.02
0.02
6.7
6.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
128
0.94
0.02
1.1
2.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
188
0.96
0.02
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
18
188
0.96
0.02
2.8
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
106
1070
0.99
0.02
1.7
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
93
1.08
0.02
5.8
2.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
275
2741
1.01
0.01
3.0
3.1
mmol/l
1.3
1.2
0.37
264
2594
(3005033) Fetal Nuchal fold Thickness US
18
187
0.96
0.01
1.5
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
243
1.03
0.01
2.7
2.1
ug/l
0.6
0.7
0.46
15
110
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
80
793
1.01
0.01
5.0
2.5
u/l
61.1
54.7
0.67
74
748
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
89
883
1.01
0.01
1.5
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
223
2223
1.01
0.01
3.2
3.1
u/l
34.4
35.7
0.13
213
2147
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
124
1.05
0.00
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
20
206
0.97
0.00
1.5
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
236
0.97
0.00
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
34
346
0.98
0.00
1.4
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
101
0.99
0.00
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
97
1.03
0.00
1.5
2.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
133
0.98
0.00
1.3
1.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
11
115
0.96
0.00
4.8
3.6
%
95.8
95.2
0.04
11
110
(3022313) Gas panel - Capillary blood
12
125
0.96
0.00
4.5
5.8
—
—
—
0
0
(3036489) Thrombin time
12
125
0.96
0.00
2.8
3.4
s
22.8
21.5
0.53
12
110
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
88
885
0.99
0.00
1.2
1.4
u/ml
0.8
1.1
0.73
26
228
(40768443) Skin Pathology biopsy report
10
96
1.04
0.00
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
16
164
0.97
0.00
1.0
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
62
616
1.01
0.00
1.9
2.1
mg/l
0.9
1.0
0.14
51
449
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
416
1.01
0.00
1.7
1.8
—
—
—
0
0
(3019225) pH of Specimen
20
196
1.02
0.00
3.4
4.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
1.3
—
0
7
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
7
0.00
0.00
0.0
1.4
—
144.7
—
0
7
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
6
0.00
0.00
0.0
1.8
—
3.8
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
63
0.95
0.00
1.2
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
55
0.91
0.00
1.2
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
89
0.90
0.00
1.6
2.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
5
0.00
0.00
0.0
3.0
—
17.0
—
0
5
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.5
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
64
0.94
0.00
1.0
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
49
1.02
0.00
4.2
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
94
0.96
0.00
14.8
9.6
mg/l
1.4
1.2
—
9
89
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
94
0.96
0.00
1.1
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
52
0.96
0.00
1.2
2.6
u/ml
60.8
3.2
—
5
45
(3013637) Mi-2 Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
6
59
1.02
0.00
4.3
5.1
mmol/l
1.3
1.3
—
6
59
(3006184) Hemoglobin [Mass/volume] in Capillary blood
5
49
1.02
0.00
2.4
2.0
g/l
129.4
131.1
—
5
36
(44806071)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
24.7
—
0.5
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CLEFT_AND_CARIES and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
Q17_CLEFT_AND_CARIES 1.835 [1.26, 2.67] 0.002
Birth year 0.988 [0.98, 1.0] 0.011

During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 1798 males with Q17_CLEFT_AND_CARIES died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CLEFT_AND_CARIES.

N-year risk Females Males
1 No data 0.411%
5 No data 2.223%
10 No data 5.802%
15 No data 10.596%
20 No data 17.778%

Relationships between endpoints

↥

Index endpoint: Q17_CLEFT_AND_CARIES – Caries in Clefts patients

GWS hits: 3

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data